Revive Therapeutics Ltd (RVVTF)

[powerbattles]

The FDA approval is HUGE could gap up to dollar base on news. There will be a lot article writes up about this stock after the approval.

This is an easy bet...

“We are very pleased with the progress that has been made with our clinical strategy for Bucillamine in the potential treatment of COVID-19, specifically with our focus on a Phase 3 confirmatory study to be conducted in the U.S. and our expansion into Canada,” said Michael Frank, Revive’s Chief Executive Officer.